fda approvals in urothelial cancer and gist, promising data in urothelial carcinoma, and more
Published 4 years ago • 226 plays • Length 9:10
Download video MP4
Download video MP3
Similar videos
-
13:01
fda approvals in urothelial cancer and prostate cancer, priority review in crc, and more
-
12:23
priority review designation in gist, promising findings in bladder cancer and nsclc, and more
-
9:27
fda approval in bladder cancer, breakthrough therapy designation in dlbcl, and more
-
8:43
fda approvals in bladder cancer and nsclc, and 2019 elcc highlights
-
0:37
dr. petrylak on fda approval of nivolumab in bladder cancer
-
1:34
dr. garcia on fda approval of pembrolizumab in bladder cancer
-
8:30
fda approvals in bladder cancer, nsclc, aml, hcc, and a breakthrough designation in nsclc
-
10:18
fda approvals in bladder cancer and hodgkin lymphoma, breakthrough designation in aml, and more
-
3:19
fda approval of durvalumab for advanced bladder cancer
-
0:38
dr. siefker-radtke on fda approval of avelumab in bladder cancer
-
1:10
dr. steinberg on the fda approval of atezolizumab in bladder cancer
-
6:49
fda approval of atezolizumab for advanced bladder cancer
-
2:03
durvalumab fda approval for bladder cancer
-
7:21
fda approval in breast cancer, breakthrough designations in aml and bladder cancer, and more
-
0:55
dr. siefker-radtke on fda approval of frontline atezolizumab in bladder cancer
-
1:49
fda approval of durvalumab for bladder cancer
-
7:05
the fda approval of atezolizumab in bladder cancer
-
0:38
dr. petrylak on fda approval of pembrolizumab in bladder cancer
-
2:39
enfortumab vedotin approved by fda for patients with refractory urothelial carcinoma
Clip.africa.com - Privacy-policy